BioXell Reports Preliminary Phase IIa Results in Non-Bacterial Chronic Prostatitis
Effect on pain comparable to placebo, effect observed on inflammation and lower urinary tract symptoms
29-Sep-2006 -
BioXell S.p.A. reported preliminary results from its proof of concept trial of Elocalcitol in patients with Non-bacterial Chronic Prostatitis. The effect of Elocalcitol was found to be no different from that of placebo on the primary endpoint, focused mainly on pelvic pain. In contrast, positive ...
benign prostatic hyperplasia
benign prostatic hypertrophy
inflammation
+4